Vanguard Group Inc Cin Cor Pharma, Inc. Transaction History

Vanguard Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$10.75 - $29.84 $1.15 Million - $3.2 Million	-107,112 Reduced 9.14%	1,064,718 $13.1 Million
Q3 2022 Nov 14, 2022	BUY	$19.9 - $38.94 $10.8 Million - $21.1 Million	541,194 Added 85.82%	1,171,830 $38.5 Million
Q2 2022 Aug 12, 2022	BUY	$13.67 - $25.74 $155,181 - $292,200	11,352 Added 1.83%	630,636 $11.9 Million
Q1 2022 May 13, 2022	BUY	$14.13 - $28.49 $8.75 Million - $17.6 Million	619,284 New	619,284 $10.9 Million

Ticker CINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,764,300
Description
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.